Enanta Pharmaceuticals
ENTA
#7451
Rank
NZ$0.72 B
Marketcap
NZ$25.27
Share price
3.62%
Change (1 day)
85.82%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -NZ$0.15 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are NZ$64.8 Million. In 2024 the company made an earning of -NZ$0.17 Billion, an increase over its 2023 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.15 Billion-13.54%
2024 -NZ$0.17 Billion-23.87%
2023 -NZ$0.23 Billion4.39%
2022 -NZ$0.22 Billion-4.4%
2021 -NZ$0.23 Billion91.12%
2020 -NZ$0.12 Billion-407.13%
2019 NZ$37.65 M-78.63%
2018 NZ$0.17 B117.97%
2017 NZ$80.84 M-574.65%
2016 -NZ$17.04 Million-110.83%
2015 NZ$0.15 B-4.5%
2014 NZ$0.16 B-638.53%
2013 -NZ$30.59 Million-137.98%
2012 NZ$80.52 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
NZ$2.87 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.72 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.96 B-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.90 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.42 B-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland